Cervín-Báez C, Ibarra-Miranda G, Acosta-Espinoza JA, Félix-Saguchi CI, Ruíz-Holguin E

Language: Spanish
References: 13
Page: 223-231
PDF size: 325.35 Kb.

ABSTRACT

We report the case of 79-year-old women with multiple risk factors of the upper airway cancer, with the main symptom of hemoptysis due to a tumor who was taking the 75% of the upper airway. A thyroid biopsy was taken with report of a malignant epithelial neoplasia composed by papillary and fibrovascular core lined by a layer of cells with a cubic and cylindrical appearance with loss of the nucleuscytoplasm ratio and hyperchromatic nuclei with pseudo inclusions, making papillary thyroid cancer the main diagnosis. In the background of a patient with story of a high smoking index, which is known as a trigger for pulmonary cancer and a x-ray image without a certain diagnosis, it’s important to evaluate the availability to perform a non-invasive procedure like the ultrasound-guided biopsy to determine the histology of the cancer and the therapeutic options.

REFERENCES

1. Vinay Kumar, Abul Abbas, Jon.C. Aster.Robbins: Patología humana.10th edición. Elsevier; 2018.

2. American Cancer Society. Cancer Facts &Figures 2022. Atlanta: American Cancer Society;2022.

3. Fernández SB, Sanchez-Díaz MR, González-Flores M, Cruz-Cruz V, Cortés-RamirezM. Perfil epidemiológico de los tumores malignosen México. SINAIS/SINAVE/DGE/SALUD/Perfil epidemiológico de los tumoresmalignos en México Secretaría de Salud.2011

4. Pizzato M, Li M, Vignat J, Laversanne M,Singh D, La Vecchia C, et al. The epidemiologicallandscape of thyroid cancerworldwide: GLOBOCAN estimates for incidenceand mortality rates in 2020 LancetDiab Endocrinol 2022;10(4):264-72.

5. Gharib H, Papini E, Paschke R, Duick DS,Valcavi R, Hegedüs L, et al.AACE/AME/ETA Task Force on Thyroid Nodules.American Association of Clinical Endocrinologists,Associazione Medici Endocrinologi,and European Thyroid AssociationMedical Guidelines for Clinical Practice forthe Diagnosis and Management of ThyroidNodules. Endocr Pract. 2010;16 Suppl 1:1-43.

6. Perros P, Boelaert K, Colley S, Evans C,Evans RM, Gerrad Ba G, et al. Guidelines forthe management of thyroid cancer, BritishThyroid Association. Clin Endococrinol2014; 81 (Suppl 1): 1-122.

7. Avenia N, Vannucci J, Monacelli M, LucchiniR, Polistena A, Santoprete S, et al. Thyroidcancer invading the airway: Diagnosis andmanagement. Int J Surg 2016; Suppl 1: S75-S78

8. Haugen BR, Alexander EK, Bible KC,Doherty GM, Mandel SJ, Nikiforov YE, et al.2015 American Thyroid Association ManagementGuidelines for Adult Patients withThyroid Nodules and Differentiated ThyroidCancer. Thyroid 2016;26(1):1-133.

9. Huang Y, Qu S, Zhu G, Wang F, Liu R, ShenX, et al. BRAFV600E mutation-assisted riskstratification of solitary intrathyroidal papillarythyroid cancer for preecision treatment.J Natl Cancer Inst. 2018;110 (4): 362-370.

10. Tahara M, Kiyota N, Hoff AO, Badiu C,Owonikoko TK, Dutcus CE, et al. Impact oflung metastases on overall survival in thephase 3 SELECT study of lenvatinib in patientswith radioiodine-refractory differentiatedthyroid cancer. Eur J Cancer.2021;147:51-57.

11. Schwartz LH, Seymour L, Litière S, Ford R,Gwyther S, Mandrekar S, et al. RECIST 1.1Standardisation and disease-specific adaptations:Perspectives from the RECIST WorkingGroup. Eur J Cancer 2016;62:138-45.

12. Haugen BR, Alexander EK, Bible KC,Doherty GM, Mandel SJ, Yuri E Nikiforov YE,et al. Risk of Structural Disease Recurrence. 2015 American Thyroid Association ManagementGuidelines for Adult Patients withThyroid Nodules and Differentiated ThyroidCancer: The American Thyroid AssociationGuidelines Task Force on Thyroid Nodulesand Differentiated Thyroid Cancer. Thyroid2016 Jan;26(1):1-133

13. Oken MM, Creech RH, Tormey DC, HortonJ, Dvis TE, McFadden ET, et al. Toxicity andResponse Criteria Of The Eastern CooperativeOncology Group. Am J Clin Oncol1982;5:649-655.